5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.68▼ | 0.67▼ | 0.67▼ | 0.67▼ | 0.66▼ |
MA10 | 0.67▼ | 0.68▼ | 0.68▼ | 0.70▼ | 0.72▼ |
MA20 | 0.68▼ | 0.70▼ | 0.71▼ | 0.67▼ | 0.82▼ |
MA50 | 0.71▼ | 0.73▼ | 0.74▼ | 0.74▼ | 1.11▼ |
MA100 | 0.74▼ | 0.69▼ | 0.68▼ | 0.84▼ | 1.27▼ |
MA200 | 0.69▼ | 0.72▼ | 0.74▼ | 1.07▼ | 3.90▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▲ | -0.004▼ | -0.005▼ | -0.002▼ | 0.001▲ |
RSI | 32.005▼ | 33.389▼ | 35.854▼ | 40.020▼ | 34.915▼ |
STOCH | 43.146 | 20.256 | 15.562▼ | 28.825 | 32.207 |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -84.497▼ | -67.994 |
CCI | -208.074▼ | -131.984▼ | -129.234▼ | -128.695▼ | -83.452 |
Tuesday, April 29, 2025 12:28 AM
Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare ...
|
Monday, April 28, 2025 01:01 PM
Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial ...
|
Monday, April 28, 2025 06:01 AM
CAMBRIDGE, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
02/05/25 | 0.6475 | 0.6475 | 0.6475 | 0.6475 | 6,414 |
01/05/25 | 0.67 | 0.684 | 0.66 | 0.66 | 27,448 |
30/04/25 | 0.67 | 0.6938 | 0.64 | 0.658 | 79,294 |
29/04/25 | 0.69 | 0.69 | 0.671 | 0.671 | 51,138 |
28/04/25 | 0.7253 | 0.743 | 0.71 | 0.71 | 46,508 |
25/04/25 | 0.725 | 0.7488 | 0.725 | 0.7252 | 71,895 |
24/04/25 | 0.74 | 0.743 | 0.72 | 0.725 | 28,949 |
23/04/25 | 0.71 | 0.7575 | 0.6266 | 0.7271 | 246,772 |
22/04/25 | 0.745 | 0.7828 | 0.72 | 0.7322 | 97,666 |
21/04/25 | 0.7542 | 0.7756 | 0.725 | 0.725 | 25,522 |
|
|
||||
|
|
||||
|
|